Market-Moving News for June 10th
$DSY
$KKR
$SKYE
Containers/Packaging
Consumer Discretionary
Investment Managers
Finance
Get the next $DSY alert in real time by email
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/28/2025 | Outperform | William Blair | ||
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities | |
| 9/30/2024 | $20.00 | Sector Outperform | Scotiabank | |
| 9/18/2024 | $148.00 | Buy | HSBC Securities | |
| 9/12/2024 | $130.00 | Equal Weight | Wells Fargo | |
| 9/10/2024 | $15.00 | Mkt Outperform | JMP Securities | |
| 8/27/2024 | $153.00 | Buy | Redburn Atlantic | |
| 7/9/2024 | $18.00 | Buy | Craig Hallum |
SC 13G/A - Skye Bioscience, Inc. (0001516551) (Subject)
SC 13G/A - Skye Bioscience, Inc. (0001516551) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4/A - Skye Bioscience, Inc. (0001516551) (Issuer)
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
Darwinbox, a leading global human resource ("HR") technology platform, today announced the signing of definitive agreements under which Partners Group, one of the largest firms in the global private markets industry (acting on behalf of its clients), and funds managed by KKR, a leading global investment firm, will co-lead an investment of $140 million in the company, with additional participation from Gravity Holdings. The addition of Partners Group and KKR to an already-solid cap-table underscores Darwinbox's strong momentum over the recent years. The investment positions Darwinbox well to deepen its technology leadership and accelerate its international expansion plans. This press release
Transaction marks significant outcome for KKR and poises Seiyu for further success KKR, a leading global investment firm, and Seiyu, a nationwide supermarket chain in Japan, today announced the signing of definitive agreements to sell Seiyu (the "Company") to Trial Holdings, Inc. (TSE stock code 141A; "Trial"), a distribution and retail business operator in Japan that operates a network of stores offering "everyday essentials" in Kyushu. This transaction represents a significant outcome for KKR and follows transformational work that positions Seiyu strongly for continued success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025
8-K - KKR & Co. Inc. (0001404912) (Filer)
CERT - KKR & Co. Inc. (0001404912) (Filer)
8-A12B - KKR & Co. Inc. (0001404912) (Filer)
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
The intelligent jobsite technology innovator secures record funding from KKR to expand data gathering and enrichment solutions. XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the acquisition of Specifx, an on-demand data enrichment and metadata retrieval platform for field service equipment. The acquisition was enabled by an investment from funds managed by leading global investment firm KKR. The funding from KKR marks the most significant milestone yet in XOi's journey to build out its system of work for the field service ecosystem. This press release features multimedia. View the full release here: https://www.businesswi
KKR, a leading global investment firm, today announced the appointment of Guy Metcalfe as Senior Advisor. In his role, Mr. Metcalfe will leverage his extensive real estate and capital markets expertise and relationship network around the world to support KKR's global real estate investment activity, platform growth and other strategic initiatives. Mr. Metcalfe previously served as Managing Director at Morgan Stanley and led its real estate investment banking business for over two decades before retiring as Global Chairman in 2024. Over his more than 30-year career at Morgan Stanley, Mr. Metcalfe was involved in more than $850 billion in transactions across multiple geographies including n
William Blair initiated coverage of Skye Bioscience with a rating of Outperform
HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $173.00
Scotiabank initiated coverage of Skye Bioscience with a rating of Sector Outperform and set a new price target of $20.00
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has priced its previously announced offering of $2.25 billion (45,000,000 shares) of its 6.25% Series D Mandatory Convertible Preferred Stock (the "mandatory convertible preferred stock") at a price to the public and liquidation preference of $50.00 per share. The offering was upsized from the previously announced size of $1.50 billion (30,000,000 shares). The underwriters have a 30-day option to purchase up to an additional $337.50 million (6,750,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. The offering is expected to close on March 7, 2025, subject to customary closing conditions.
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has commenced an offering of $1.5 billion (30,000,000 shares) of its Series D Mandatory Convertible Preferred Stock, par value $0.01 per share (the "mandatory convertible preferred stock"), subject to market and other conditions (the "offering"). KKR expects to grant the underwriters a 30-day option to purchase up to an additional $225 million (4,500,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. KKR intends to use the net proceeds from the offering for the acquisition of additional equity interests in core private equity portfolio companies reported in its Strategic Holdings segment a
PHILADELPHIA and NEW YORK, Feb. 26, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2024, and that its board of directors has declared a first quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2024(1) Net investment income of $0.61 per share, compared to $0.77 per share for the quarter ended September 30, 2024Adjusted net investment income(2) of $0.66 per share, compared to $0.74 per share for th
